Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods
NCT ID: NCT02290288
Last Updated: 2015-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138 participants
INTERVENTIONAL
2005-10-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse
NCT04172896
Vaginal Vault Suspension During Benign Hysterectomy. A Questionnaire and Register-based Study.
NCT02859272
Post-hysterectomy Vaginal Cuff Prolapse Repair
NCT07174921
Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse
NCT05063331
Compare Sacrospinous Fixation Versus High Uterosacral Ligament Fixation for Uterus Vaginal Prolapse III/IV
NCT01347021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is some evidence indicating that laparoscopic surgery can be superior to the vaginal approach. Symptoms of prolapse are significantly associated with avulsion injury in patients after hysterectomy.
Our aim is to compare, with a 1- and 2-years follow-up examination in patients with post-hysterectomy prolapse, the efficacy of two standard surgical procedures for vaginal vault prolapse: sacrospinous vaginal colpopexy (the Richter procedure) with native tissue vaginal repair (sacrospinous fixation, SSF) and laparoscopic colposacropexy with mesh.
This is a single-center, randomized controlled trial of two standard surgical procedures for vaginal vault prolapse routinely used at our institution.Both procedures are designed to treat vault prolapse, one with mesh implantation through laparoscopy and the other with vaginal repairs and apical fixation to the sacrospinous ligament, usually on the right.
All patients referred to our gynecological unit (Ob/Gyn Department of Sahlgrenska University Hospital in Gothenburg) because of symptomatic vault prolapse and fulfilling the inclusions criteria are asked to participate in the study. Eligible for inclusion are: post-hysterectomy patients with at least two-compartment prolapse (with affected apical/vault compartment, stage II or higher on the Pelvic Organ Prolapse Quantification system (POP-Q)), suffering from symptoms of prolapse, requesting pelvic floor reconstructive surgery, and diagnosed with a vault prolapse. Excluded are: patients with prolapse and uterus in place, those not requesting pelvic floor surgery, patients who do not understand Swedish or are not capable to fulfill follow up procedure.
Patients undergo identical pre- and postoperative assessment procedures, including POP-Q examination on maximum Valsalva maneuver, which are archived on Case Report Form, and validated questionnaires PFDI-20, PFIQ-7 and PISQ-12. The study was approved by the regional ethics committee and all subjects obtain written informed consent to participate. To minimize the bias we decided that all the follow up examinations are going to be performed by the same gynecologist who do not perform the surgery.
All patients can end participation in the study at any moment.
The randomization process is carried out by computer, using patient social security number, at the time of enrollment (usually 2-3 months before the surgery). Patients are informed about their allocation after the randomization. Both procedures are performed by an experienced surgeon, with the patient under general anesthesia for the laparoscopic procedure and regional anesthesia for the sacrospinous fixation.
Patients are followed up at 3 months,1 year and 2 years postoperatively. These postoperative clinical examinations are performed by a single examiner, who had not been involved in the surgical procedures. The vaginal descent was assessed at maximum Valsalva maneuver.
In case of recurrence of prolapse and distressing symptoms which a patient desired to be resolved, a reoperation of prolapse is planned according to the clinical praxis at our department.
The primary outcome measure was anatomical failure based on clinical assessment. Failure was defined clinically as Ba, C or Bp at the hymen or below, on maximum Valsalva maneuver.
As secondary outcome measures we used a continence status, sexual function and prolapse symptoms based on validated questionnaires: Pelvic Floor Impact Questionnaire (PFIQ - 7), Pelvic Floor Distress Inventory Questionnaire - Short Form 20 (PFDI-20), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and quality of life based on Short Form (36) Health Survey.
The power calculation was based on the primary outcome measure and available data which led us to expect a failure rate of 25% in the sacrospinous fixation group and 10% failure in laparoscopy group. To detect an expected difference of 15% between the groups, with 80% power of the test 70 patients are required in each group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SSF
1\. vaginal surgery arm (SSF)
vaginal surgery
LSC
laparoscopic surgery arm (LSC)
laparoscopic surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vaginal surgery
laparoscopic surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* stage II or higher on the Pelvic Organ Prolapse Quantification system (POP-Q)),
* suffering from symptoms of prolapse,
* requesting pelvic floor reconstructive surgery, and
* diagnosed with a vault prolapse.
Exclusion Criteria
* those not requesting pelvic floor surgery,
* patients who do not understand Swedish or are not capable to fulfill follow up procedure
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Janusz Marcickiewicz
senior consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Obst Gyn, Sahlgrenska University Hospital
Gothenburg, VGR, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VGFOUREG-28601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.